Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AR1Y
|
|||
| Former ID |
DNC009975
|
|||
| Drug Name |
1,4-bis(malimido)xylene
|
|||
| Synonyms |
1,4-bis(malimido)xylene; CHEMBL565711; SCHEMBL146412; BDBM50300349
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12N2O4
|
|||
| Canonical SMILES |
C1=CC(=CC=C1CN2C(=O)C=CC2=O)CN3C(=O)C=CC3=O
|
|||
| InChI |
1S/C16H12N2O4/c19-13-5-6-14(20)17(13)9-11-1-2-12(4-3-11)10-18-15(21)7-8-16(18)22/h1-8H,9-10H2
|
|||
| InChIKey |
XFRPTDABLAIJMY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.